JPWO2022250050A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022250050A5 JPWO2022250050A5 JP2023523485A JP2023523485A JPWO2022250050A5 JP WO2022250050 A5 JPWO2022250050 A5 JP WO2022250050A5 JP 2023523485 A JP2023523485 A JP 2023523485A JP 2023523485 A JP2023523485 A JP 2023523485A JP WO2022250050 A5 JPWO2022250050 A5 JP WO2022250050A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- double
- acid strand
- stranded nucleic
- acid complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021087941 | 2021-05-25 | ||
| PCT/JP2022/021251 WO2022250050A1 (ja) | 2021-05-25 | 2022-05-24 | ｓｃｐＢＮＡ又はＡｍＮＡを含むヘテロ核酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022250050A1 JPWO2022250050A1 (https=) | 2022-12-01 |
| JPWO2022250050A5 true JPWO2022250050A5 (https=) | 2025-06-03 |
Family
ID=84228791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523485A Pending JPWO2022250050A1 (https=) | 2021-05-25 | 2022-05-24 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240240183A1 (https=) |
| EP (1) | EP4349986A4 (https=) |
| JP (1) | JPWO2022250050A1 (https=) |
| CA (1) | CA3221584A1 (https=) |
| WO (1) | WO2022250050A1 (https=) |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264423A (en) | 1987-03-25 | 1993-11-23 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors for replication of retroviruses and for the expression of oncogene products |
| US5276019A (en) | 1987-03-25 | 1994-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors for replication of retroviruses and for the expression of oncogene products |
| US5955599A (en) | 1995-06-01 | 1999-09-21 | Hybridon, Inc. | Process for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkages |
| WO2005073378A1 (en) * | 2004-01-30 | 2005-08-11 | Santaris Pharma A/S | MODIFIED SHORT INTERFERING RNA (MODIFIED siRNA) |
| EP2023940B1 (en) | 2006-05-05 | 2011-06-22 | Isis Pharmaceuticals, Inc. | Compounds and methods for modulating expression of sglt2 |
| ES2603379T3 (es) | 2006-10-09 | 2017-02-27 | Roche Innovation Center Copenhagen A/S | Compuestos antagonistas de ARN para la modulación de PCSK9 |
| WO2008049085A1 (en) | 2006-10-18 | 2008-04-24 | Isis Pharmaceuticals, Inc. | Antisense compounds |
| AU2012353330B2 (en) | 2011-12-16 | 2018-04-19 | National University Corporation Tokyo Medical And Dental University | Chimeric double-stranded nucleic acid |
| ES2700277T3 (es) | 2013-05-30 | 2019-02-14 | Univ Nat Corp Tokyo Medical & Dental | Agentes de doble cadena para el suministro de oligonucleótidos terapéuticos |
| WO2015125783A1 (ja) * | 2014-02-18 | 2015-08-27 | 国立大学法人大阪大学 | 架橋型ヌクレオシドおよびヌクレオチド |
| DK3137476T3 (da) | 2014-04-28 | 2019-11-18 | Ionis Pharmaceuticals Inc | Linker-modificerede oligomerforbindelser |
| EP3221330B1 (en) | 2014-11-18 | 2026-04-22 | Zata Pharmaceuticals Inc. | Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds |
| EP3517610A4 (en) * | 2016-09-23 | 2020-05-27 | National University Corporation Tokyo Medical and Dental University | THROUGH HETERODUPLEX NUCLEIC ACID THROUGH BLOOD BRAIN CABINET |
| US11260134B2 (en) | 2016-09-29 | 2022-03-01 | National University Corporation Tokyo Medical And Dental University | Double-stranded nucleic acid complex having overhang |
| JPWO2018221649A1 (ja) * | 2017-05-31 | 2020-04-02 | 協和キリン株式会社 | Ａｐｃｓの発現を抑制する核酸 |
| PE20211783A1 (es) * | 2018-11-08 | 2021-09-08 | Aligos Therapeutics Inc | Polimeros oligonucleotidos que inhiben el transporte de antigenos y metodos |
| EP3954395A4 (en) * | 2019-04-08 | 2023-06-28 | National University Corporation Tokyo Medical and Dental University | Pharmaceutical composition for muscle disease treatment |
| JP7793144B2 (ja) * | 2019-10-11 | 2026-01-05 | 国立大学法人東京科学大学 | 修飾ヘテロ核酸 |
| JP7537896B2 (ja) | 2019-11-21 | 2024-08-21 | 日本無機株式会社 | エアフィルタ |
-
2022
- 2022-05-24 US US18/563,128 patent/US20240240183A1/en active Pending
- 2022-05-24 JP JP2023523485A patent/JPWO2022250050A1/ja active Pending
- 2022-05-24 CA CA3221584A patent/CA3221584A1/en active Pending
- 2022-05-24 EP EP22811320.5A patent/EP4349986A4/en active Pending
- 2022-05-24 WO PCT/JP2022/021251 patent/WO2022250050A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230020192A1 (en) | Compounds and methods for modulating c90rf72 | |
| CN113164509B (zh) | 用于抑制17β-HSD 13型(HSD17B13)表达的RNAi试剂、其组合物和使用方法 | |
| DE60038495T2 (de) | Oligonukleotid n3'-p5' thiophosphoramidate: ihre synthese und verwendung | |
| JP2019214587A5 (https=) | ||
| JPWO2020209285A5 (https=) | ||
| JPWO2023022229A5 (https=) | ||
| JP2021533804A5 (https=) | ||
| CN110832077B (zh) | 用于抑制α-ENaC表达的RNAi剂及使用方法 | |
| TWI803455B (zh) | 單股寡核苷酸 | |
| IL264216B2 (en) | Compounds and methods for modulation of smn2 | |
| JP2019525918A5 (https=) | ||
| CN120475978A (zh) | 用于抑制DM1蛋白激酶(DMPK)表达的RNAi剂、其组合物和使用方法 | |
| KR20240129626A (ko) | 변형된 백본 화학을 갖는 스플라이스 스위처 안티센스 올리고뉴클레오티드 | |
| CN120505310A (zh) | 用于调节smn2的化合物和方法 | |
| WO2024140101A1 (zh) | 修饰的双链寡核苷酸分子、修饰的双链寡核苷酸缀合物及其用途 | |
| AU2017297624B2 (en) | Compounds and methods for modulation of transcript processing | |
| Koch et al. | Locked nucleic acid | |
| JPWO2021187392A5 (https=) | ||
| WO2019044974A1 (ja) | スモールガイドアンチセンス核酸とその使用 | |
| JPWO2020160163A5 (https=) | ||
| JPWO2022250050A5 (https=) | ||
| WO2021157730A1 (ja) | 核酸医薬とその使用 | |
| JP6934695B2 (ja) | 核酸医薬とその使用 | |
| TW202309286A (zh) | 作為新穎基因靜默技術的非對稱短雙股ｄｎａ及其應用 | |
| JPWO2020190740A5 (https=) |